About: Measures to control blood activation during assisted circulation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Measures to control blood activation during assisted circulation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1998 (uk) im November 1998 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1998 (en) artículu científicu espublizáu en payares de 1998 (ast)
publication date	wds:Q77754739-EC55FED7-CAB2-489F-8A32-21CCFCED92C2
publication date	1998-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77754739-22D5D2FD-3115-47C8-BAE9-5567A64BF83B
language of work or name	English
cites work	wds:Q77754739-08B430BF-F240-4CDD-857F-1CC87A6E2F5F wds:Q77754739-1127A6FC-3F02-46DE-8078-D2EF3286018C wds:Q77754739-1D33CC8C-A1F7-4614-863B-6D7598FFC647 wds:Q77754739-1E1D0BBB-ED98-421F-9707-417CC3F43DCC wds:Q77754739-248FEAB0-2145-40BD-A4A7-3EA1FF9220E5 wds:Q77754739-251ED62D-042D-45DF-8292-23D2F3976BD5 wds:Q77754739-25CE6E9E-A3B9-4E67-90E2-F964A0F8B688 wds:Q77754739-2843A9AE-BC31-4CBB-B467-216E531AAD36 wds:Q77754739-28447281-CE5B-484C-8EF9-F7C42668B00C wds:Q77754739-2E8ED967-9B5D-47C3-92FB-C537AC8C4EC9 wds:Q77754739-31A181E8-C40D-4DB0-835A-A2D7AF869325 wds:Q77754739-37D74C9B-7E91-4DC8-A8C1-BE7B5B5805D4 wds:Q77754739-3C35FEED-06B7-414B-8DD4-735C84474402 wds:Q77754739-4869D47A-1F5C-44FD-86EB-8CAE7A07692E wds:Q77754739-4F2392BC-D96C-4665-A600-85BEA77B9026 wds:Q77754739-4F59A4A8-E3BD-4166-9D06-D2E7FDD779A0 wds:Q77754739-626C537A-34B3-4E26-A568-19A4221B30A2 wds:Q77754739-6FF26F2A-5D41-430B-8607-FBEDA51B10FA wds:Q77754739-70EFEEB3-6682-4230-93E6-D7D22C0015C6 wds:Q77754739-721D5F43-B1DB-49AA-A3B4-EE36581CE2B7 wds:Q77754739-76035BD2-8926-4A62-8B6E-B5F6A85CE3FC wds:Q77754739-76D28CA6-AB8E-48AE-9E97-57E43872A94F wds:Q77754739-854F4F80-5689-4C37-8FFA-F614657B9352 wds:Q77754739-91671D46-C90E-4623-AC51-89D624DC26B3 wds:Q77754739-949BAE43-D7E0-4215-9CFA-618CDD01B9A1 wds:Q77754739-A29AD2B2-A0CF-4760-9FA1-18CBDC726936 wds:Q77754739-AC84AF64-ECCD-412F-ADCA-ABF1BB659CEB wds:Q77754739-AFA184AB-F3EB-46EA-AD89-63C02B10620F wds:Q77754739-B94EDD7F-FA5B-4122-A2AE-E678FD0748C6 wds:Q77754739-C170A4BA-5B41-477B-80E7-EA5ADE1555F7 wds:Q77754739-C33DE38A-9792-44FC-A27F-B512834A301C wds:Q77754739-CDFB074A-CF5E-4666-AF2D-384167B44008 wds:Q77754739-D8DA0399-F187-485A-A7BD-7F735152CD0A wds:Q77754739-D961ABC6-F29C-430E-9B6E-71610B476D10 wds:Q77754739-DA4D2D97-77B5-461D-92AA-C2C2D413B57E wds:Q77754739-DCC4292B-E2EA-4A9F-B207-BC10528C256D wds:Q77754739-E4E30D97-B197-4312-B5FB-061436E0E5AC wds:Q77754739-E7347B09-0FC4-4E77-ABD5-CAE555725A83 wds:Q77754739-EEDD6B5A-2D20-4A3B-82BA-5913EF6F639A wds:Q77754739-EF4FF5CE-0106-4164-9A7E-677E738441D8 wds:Q77754739-FB62A290-DCAF-4D89-90A9-5DC8E9831AF0 wds:Q77754739-FC7C2C49-236B-4FD0-B941-AE4C1229E888
cites work	Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response Blood contact activation: pathophysiological effects and therapeutic approaches Inhibition of neutrophil adhesion during cardiopulmonary bypass Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells Blood-surface interactions during cardiopulmonary bypass. Inflammatory response to cardiopulmonary bypass Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device. Molecular approaches to the characterization of cell and blood/biomaterial interactions Endothelial cell injury in cardiovascular surgery: the procoagulant response Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass Properties of blood-contacting surfaces of clinically implanted cardiac assist devices: gene expression, matrix composition, and ultrastructural characterization of cellular linings Aprotinin effect on platelet function and clotting during cardiopulmonary bypass Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials Protein adsorption and cellular adhesion and activation on biomedical polymers Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass Perfusion-related factors of endotoxin release during cardiopulmonary bypass Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass Albumin immobilized polyurethane and its blood compatibility Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation Complement activation during cardiopulmonary bypass: Effects of immobilized heparin "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Endothelial cell seeding Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit Improving the interface between biomaterials and the blood. The gene therapy approach Heparin coating with aprotinin reduces blood activation during coronary artery operations. Hemostatic abnormalities in total artificial heart patients as detected by specific blood markers Reduction of blood activation in patients receiving aprotinin during cardiopulmonary bypass for coronary artery surgery Surface coating of cardiopulmonary bypass circuits Blood contact with artificial surfaces during BVAD support.
author name string	wds:Q77754739-995211AA-B08E-43D7-8BD2-8BB4AF1CAD56 wds:Q77754739-B7A807CE-A83F-4EFB-AD8E-A573253AC720 wds:Q77754739-ECCB24F7-9CB5-4894-AC24-54B48447D4D6
author name string	M Kirsch C Baufreton D Y Loisance

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software